Glycemic Research Institute issues warning on agave syrup -The Medical Advisory Board of the Glycemic Research Institute (GRI) made a decision to halt all future clinical trials involving Agave as a result of the latest round of GRI Human In Vivo Clinical Trials, in which the diabetic subjects experienced severe and dangerous side effects related to the oral ingestion of the sweetener agave.. click here read the full alert - or - http://www.glycemic.com/AgaveReport.html.
